This article explains the current status and prospects of preclinical models using human cells for the development of next-generation therapeutic drugs for primary ciliary dyskinesia (PCD), a rare ...

Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial will test a novel ...

Plus: SpaceX has officially delivered the largest IPO in history. This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before. Earlier this week, Life Biosciences, a biotech company focused on reversing age-related ...

In a breakthrough for longevity science, a reverse-aging treatment has been injected into a human. The technique is a sought-after solution for improving longevity by reprogramming cells. Competitors ...

A longevity startup has dosed its first patient with a drug to reverse age-related sight loss. Life Biosciences is testing its ER-100 drug, which the company claims has restored vision in monkeys, for ...

Findings from this study are considered fundamental because they identify amino acid uptake, cholesterol synthesis, and protein prenylation as key metabolic regulators of B cell activation, ...

Gear-obsessed editors choose every product we review. We may earn commission if you buy from a link. Why Trust Us? Here’s what you’ll learn when you read this story: A scientist wants to reprogram ...

SIRT5 (sirtuin 5) is a member of the sirtuin family known to regulate cardiac metabolism, aging, and function. However, its role in cardiac fibroblast (CFB) metabolism, activation, and fibrosis ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance.

St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the rest of the immune system to the presence of cancer—and how restoring their ...

April 2 (Reuters) - Coinbase Global (COIN.O), opens new tab has received conditional approval from banking regulators for ‌a national trust company charter, it said on Thursday, a move that could ...